Abcore

Abcore is a life science tools and antibody discovery company focused on custom antibody generation, phage display-based binder discovery, and single-domain antibody (VHH/nanobody) services. The company has provided polyclonal, monoclonal, recombinant, and camelid-derived antibody solutions for research, diagnostic, and early therapeutic discovery customers. Abcore is best known for its proprietary naïve and immunized phage display libraries and for end-to-end support of antibody and nanobody discovery programs. In March 2022, Abcore was acquired by Fortis Life Sciences and now operates as part of the Fortis portfolio. The business appears to remain active post-acquisition as a branded operating unit within Fortis.